Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""lung"" wg kryterium: Temat


Wyświetlanie 1-7 z 7
Tytuł:
Electrocardiographic changes in lung cancer. Be careful not to misdiagnose: acute coronary event?, meta?, inflammation?
Autorzy:
Styczkiewicz, Katarzyna
Kostkiewicz, Agnieszka
Górecki, Michał
Iwański, Mateusz A.
Powiązania:
https://bibliotekanauki.pl/articles/44427697.pdf
Data publikacji:
2024-04-07
Wydawca:
Medical Education
Tematy:
electrocardiogram
lung cancer
myocardial oedema
Opis:
In cancer patients changes in the electrocardiogram (ECG) may indicate various causes. The presented case concerns a patient with advanced left lung cancer who presented deep inversion of T waves during ongoing chemotherapy. We excluded acute coronary syndrome, acute pulmonary embolism, and myocarditis. Subsequently, we suspected metastases to the myocardium; therefore, we performed cardiac magnetic resonance imaging, which however did not confirm that. The cardiac magnetic resonance imaging showed residual post-inflammatory changes in the left lung. We publish this case to show that the inflammatory process of lung segments adjacent to the heart may cause temporal myocardial oedema, resulting in ECG changes that may mimic acute coronary events.
Źródło:
OncoReview; 2024, 14, 1; 16-20
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Intraocular metastasis of small cell lung cancer: a case report
Autorzy:
Pażyra, Aldona
Kusak, Natalia
Żak, Natalia
Jaworska, Barbara
Powiązania:
https://bibliotekanauki.pl/articles/44424309.pdf
Data publikacji:
2024-01-09
Wydawca:
Medical Education
Tematy:
intraocular metastasis
SCLC
small cell lung cancer
Opis:
We report a rare case of intraocular metastasis of small cell lung cancer with disease progression.
Źródło:
OncoReview; 2023, 13, 4; 99-102
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Everolimus-induced interstitial lung disease in patient with metastatic renal cell carcinoma – case report and literature review
Autorzy:
Buraczewska, Agnieszka
Kardas, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/1065282.pdf
Data publikacji:
2015
Wydawca:
Medical Education
Tematy:
everolimus
interstitial lung disease
metastatic renal cell carcinoma
Opis:
We present a case of a 70-year-old man with metastatic renal cell carcinoma treated with second-line everolimus after rapid progression on first-line tyrosine kinase inhibitor, in whom a side effect of the therapy occurred in the form of a drug-induced interstitial lung disease. We also provide a review of the literature concerning opinions on incidence, clinical picture, consequences and management of the complication discussed.
Źródło:
OncoReview; 2015, 5, 3; A117-121
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
From suspicion of angioedema to the diagnosis of lung cancer
Autorzy:
Moos, Łukasz
Żurek, Wojciech
Kapeluszna, Katarzyna
Brzoza, Zenon
Powiązania:
https://bibliotekanauki.pl/articles/1035924.pdf
Data publikacji:
2020-10-25
Wydawca:
Medical Education
Tematy:
AAE
HAE
angioedema
lung cancer
superior vena cava syndrome
Opis:
Angioedema is a localized and self-limiting oedema of the subcutaneous and submucosal tissue. Case presentation: 73-year-old man was admitted to the Division of Allergology with the diagnosis of angioedema. Detailed physical examination led to the suspicion of superior vena cava syndrome with secondary face swelling. Biopsy revealed metastasis of small cell carcinoma in superclavicular lymph nodes. Conclusions: Facial swelling, especially recurrent and non-inflammatory, is often, but not always caused by angioedema. Insightful differential diagnosis is crucial before making the final one.
Źródło:
OncoReview; 2020, 10, 3; 108-112
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
A patient with lung cancer and increased right ventricular pressure – should all lung cancer patients be suspected of pulmonary embolism?
Autorzy:
Styczkiewicz, Katarzyna
Mędrek, Sabina
Adamowicz, Adam
Styczkiewicz, Marek
Powiązania:
https://bibliotekanauki.pl/articles/1035688.pdf
Data publikacji:
2019
Wydawca:
Medical Education
Tematy:
lung cancer
pulmonary embolism
pulmonary hypertension
right ventricle pressure
Opis:
Lung cancer is associated with an increased risk of venous thromboembolism, including pulmonary embolism. In some situations, clinical deterioration in patients with lung cancer accompanied by elevated pressure in the right ventricle, usually measured by commonly used echocardiography, may support the diagnosis of pulmonary embolism. However, there are many other causes of increased pressure in the right ventricle in such patients, for example: progression of cancer, pre-existing lung diseases, surgical resection of pulmonary tissue, pnemotoxicity of radiotherapy or concomitant diseases of the left heart. The article presents 2 clinical cases of patients with lung cancer, in which elevated pressure in the right ventricle was resulted from other causes and accompanied the progression of cancer, despite the clinical picture suggesting a pulmonary embolism. Increased pressure in the right ventricle and usually associated pulmonary hypertension, significantly worsen already poor prognosis of patients with lung cancer. The differential diagnosis should, therefore, take into account the whole clinical picture, excluding venous thromboembolism as an important cause of pulmonary hypertension, but also take into account other potential factors to be able to make the right diagnosis and implement optimal treatment as early as possible.
Źródło:
OncoReview; 2019, 9, 2; 45-50
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Percutaneous vena cava superior angioplasty and stenting as an effective method of treatment in vena cava superior syndrome in the course of lung cancer
Autorzy:
Darocha, Szymon
Szmit, Sebastian
Pietura, Radosław
Kurzyna, Marcin
Powiązania:
https://bibliotekanauki.pl/articles/1065677.pdf
Data publikacji:
2014
Wydawca:
Medical Education
Tematy:
lung cancer
vena cava superior stenting
vena cava superior syndrome
Opis:
Vena cava superior syndrome (VCSS) is a sudden life-threatening condition encountered in patients with neoplasms. The prognosis depends on histopathological diagnosis, severity of clinical symptoms and administered treatment. Depending on the type of neoplasm, the treatment of choice may be radiotherapy or chemotherapy. In patients with rapidly increasing clinical symptoms the justified management is percutaneous balloon angioplasty of the superior vena cava with the placement of stents.
Źródło:
OncoReview; 2014, 4, 3; A108-112
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The evaluation of the efficacy and toxicity of targeted treatment in non-small cell lung cancer patients – single centre experience
Autorzy:
Kardas, Joanna
Buraczewska, Agnieszka
Chrom, Paweł
Waśko-Grabowska, Anna
Młot, Beata
Szczylik, Cezary
Powiązania:
https://bibliotekanauki.pl/articles/773534.pdf
Data publikacji:
2017
Wydawca:
Medical Education
Tematy:
endothelial growth factor receptor
non-small cell lung cancer
tyrosine kinase inhibitor
Opis:
Introduction: Tyrosine kinase inhibitors (TKI) are the standard of treatment in patients with advanced non-small cell lung cancer (NSCLC) with EGFR (endothelial growth factor receptor) gene activating mutation. Objective: The evaluation of the efficacy and toxicity of TKI drugs in NSCLC patients treated in single centre. Material and methods: NSCLC patients treated with TKI (gefitinib, erlotynib, afatinib) between 2012– 2016 were retrospectively analysed. We evaluated: overall response rate (ORR) which is the sum of complete responses (CR) and partial remissions (PR), progression free survival (PFS), overall survival (OS) and adverse events (AE) according to CTCAE (Common Terminology Criteria for Adverse Events) scale. Results: The study group were 16 patients ORR was 50% (CR: 1, PR: 7). Median PFS and OS was 8,7 and 22,9 months respectively. Adverse events observed mainly in stage 1 and 2 were related to hyponatraemia, hyperbilirubinemia, skin toxicity and mucositis. There was one death reported due to infectious complications. Conclusion: The efficacy and toxicity of TKI in study group were found to be similar to those described in the literature.
Źródło:
OncoReview; 2017, 7, 2; 92-97
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies